These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 32096496)

  • 21. [Intraprostatic calcifications as natural fiducial markers in image-guided radiotherapy for prostate cancer].
    Sbai A; Thariat J; Tachfouti N; Pan Q; Lagrange JL
    Cancer Radiother; 2014 Dec; 18(8):740-4. PubMed ID: 25451671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Erratum to: Comparison of Adjuvant Versus Salvage Radiotherapy Policies for Postprostatectomy Radiotherapy. Int J Radiat Oncol Biol Phys 2004;59:329-340.
    Int J Radiat Oncol Biol Phys; 2018 Oct; 102(2):471. PubMed ID: 30191883
    [No Abstract]   [Full Text] [Related]  

  • 23. Erratum to: Hafeez S, McDonald F, Lalondrelle S, et al. Clinical outcomes of image guided adaptive hypofractionated weekly radiation therapy for bladder cancer in patients unsuitable for radical treatment. Int J Radiat Oncol Biol Phys 2017;98:115-122.
    Int J Radiat Oncol Biol Phys; 2018 Feb; 100(2):532-533. PubMed ID: 29353666
    [No Abstract]   [Full Text] [Related]  

  • 24. Volumetric modulated arc therapy for delivery of prostate radiotherapy: in regard to Palma et al. (Int J Radiat Oncol Biol Phys 2008;70:996-1001).
    Ost P; Fonteyne V; De Neve W; De Gersem W; De Wagter C; Vandecasteele K; Duprez F; De Meerleer G
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1286; author reply 1287. PubMed ID: 19251105
    [No Abstract]   [Full Text] [Related]  

  • 25. In regard to Purdy JA, Michalski JM. Does the evidence support the enthusiasm over 3D conformal radiation therapy and dose escalation in the treatment of prostate cancer? Int J Radiat Oncol Biol Phys 2001;51:867-870.
    Levitt SH; Khan FM
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(4):1085; author reply 1085-6. PubMed ID: 12095577
    [No Abstract]   [Full Text] [Related]  

  • 26. In regard to Trofimov et al.: Radiotherapy treatment of early-stage prostate cancer with IMRT and protons: a treatment planning comparison (Int J Radiat Oncol Biol Phys 2007;69:444-453).
    Albertini F; Lomax AJ; Hug EB
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1333-4; author reply 1334-5. PubMed ID: 17967323
    [No Abstract]   [Full Text] [Related]  

  • 27. Erratum to: Pollack A, Chinea FM, Bossart E, Kwon D, Abramowitz MC, Lynne C, Jorda M, Marples B, Patel VN, Wu XD, Reis I, Studenski MT, Casillas J, Stoyanova R. Phase I Trial of MRI-Guided Prostate Cancer Lattice Extreme Ablative Dose (LEAD) Boost Radiation Therapy. Int J Radiat Oncol Biol Phys 2020;107:305-315.
    Int J Radiat Oncol Biol Phys; 2020 Sep; 108(1):328. PubMed ID: 32819616
    [No Abstract]   [Full Text] [Related]  

  • 28. In regard to "Dose escalation in the radiation therapy of prostate cancer" (Int J Radiat Oncol Biol Phys 2011;80:1289-1291).
    Bowes D; Crook J
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1317-8. PubMed ID: 22385710
    [No Abstract]   [Full Text] [Related]  

  • 29. In regards to Thames et al.: increasing external beam dose for T1-T2 prostate cancer: effect on risk groups. (Int J Radiat Oncol Biol Phys 2006;65:975-981).
    Pickles T; Williams SG
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):318-9; author reply 319. PubMed ID: 17189080
    [No Abstract]   [Full Text] [Related]  

  • 30. Adjuvant radiotherapy after prostatectomy: does waiting for a detectable prostate-specific antigen level make sense?: in regard to King CR (Int J Radiat Oncol Biol Phys 2011;80:1-3).
    Catton CN; Parker CC; Sydes MR
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1594. PubMed ID: 22115563
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical experience with image-guided radiotherapy in an accelerated partial breast intensity-modulated radiotherapy protocol: in regard to Leonard CE et al. (Int J Radiat Oncol Biol Phys Epub May 19, 2009).
    Gierga DP; Taghian AG; Chen GT
    Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):315; author reply 315. PubMed ID: 20005463
    [No Abstract]   [Full Text] [Related]  

  • 32. Technique of Injection of Hyaluronic Acid as a Prostatic Spacer and Fiducials Before Hypofractionated External Beam Radiotherapy for Prostate Cancer.
    Boissier R; Udrescu C; Rebillard X; Terrier JE; Faix A; Chapet O; Azria D; Devonec M; Paparel P; Ruffion A
    Urology; 2017 Jan; 99():265-269. PubMed ID: 27725233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PSA failure and the risk of death in prostate cancer patients treated with radiotherapy: in regard to Kwan et al. (Int J Radiat Oncol Biol Phys 2004;60:1040-1046).
    Williams S
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1253-4; author reply 1254. PubMed ID: 15990030
    [No Abstract]   [Full Text] [Related]  

  • 34. In regard to Fiorino et al.: Rectal dose-volume constraints in high-dose radiotherapy of localized prostate cancer (Int J Radiat Oncol Biol Phys 2003;57:953-962).
    Bauman G; Rodrigues G
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):912-4; author reply 914-5. PubMed ID: 15183497
    [No Abstract]   [Full Text] [Related]  

  • 35. In regard to Kupelian et al.: Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seed/external beam radiotherapy for stage T1-T2 prostate cancer (Int J Radiat Oncol Biol Phys 2004;58:25-33).
    Halperin RM
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):631-2; author reply 632. PubMed ID: 15667989
    [No Abstract]   [Full Text] [Related]  

  • 36. Response to "The rate of secondary malignancies after radical prostatectomy versus external beam radiation therapy for localized prostate cancer: a population-based study on 17,845 patients." (Int J Radiat Oncol Biol Phys 2010;76:342-348).
    Froehner M; Wirth MP
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1279; author reply 1280. PubMed ID: 20542389
    [No Abstract]   [Full Text] [Related]  

  • 37. Response to "the impact of pretreatment prostate volume on severe acute genitourinary toxicity in prostate cancer patients treated with intensity-modulated radiation therapy" (Int J Radiat Oncol Biol Phys 2011;79:379-384).
    Oymak E; Onal C
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1603; author reply 1603-4. PubMed ID: 21740997
    [No Abstract]   [Full Text] [Related]  

  • 38. Pelvic nodal radiotherapy in patients with unfavorable intermediate and high-risk prostate cancer: evidence, rationale, and future directions: in regard to Morikawa and Roach III (Int J Radiat Oncol Biol Phys 2011 May 1;80:6-16).
    Revannasiddaiah S; Gupta MK; Seam RK; Madabhavi I
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1318; author reply 1318. PubMed ID: 22385711
    [No Abstract]   [Full Text] [Related]  

  • 39. Using Bayesian logistic regression to evaluate a new type of dosimetric constraint for prostate radiotherapy treatment planning.
    Buettner F; Gulliford SL; Webb S; Partridge M
    Med Phys; 2010 Apr; 37(4):1768-77. PubMed ID: 20443499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Erratum to: Nguyen PL. Rethinking the Balance of Risk and Benefit of Androgen Deprivation Therapy for Intermediate-Risk Prostate Cancer. Int J Radiat Oncol Biol Phys 2016;94:975-977.
    Int J Radiat Oncol Biol Phys; 2016 Aug; 95(5):1549. PubMed ID: 27479731
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.